Subtype
Throat Carcinoma
CI-CAN-00006917Explore in graph →
369 active trials1 approved drugs2 evidence items
- NCIt
- C35506
Loading cancer entity…
Subtype
CI-CAN-00006917Explore in graph →
Clinical trials
1,035 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (87)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04292990 | Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients | unknown | Phase 4 | 300 | Jiarong Chen, MDOTHER | 0 | Jul 29, 2020 | clinicaltrials |
| NCT02293356 | Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma | unknown | Phase 4 | 2,000 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Aug 19, 2015 | clinicaltrials |
Showing 1–2 of 2 studies
Data updated 22 days agoSource updated Jul 29, 2020source: clinicaltrials